Otonomy Announces Exclusive License Agreement with Kyorin for Novel Compound in OTO-6XX Hearing Loss Program

Go back to Otonomy Announces Exclusive License Agreement with Kyorin for Novel Compound in OTO-6XX Hearing Loss Program
(NASDAQ: OTIC) Delayed: 1.80 +0.05 (2.86%)
Previous Close $1.75    52 Week High $30.75 
Open $1.75    52 Week Low $10.50 
Day High $1.80    P/E N/A 
Day Low $1.72    EPS $0.00 
Volume 161,390